Genetics and Genomics of Chronic Pancreatitis with a Focus on Disease Biology and Molecular Pathogenesis

Abstract

Chronic pancreatitis is a long-term fibroinflammatory condition of the pancreas with varying incidences across countries. The recent increase in its occurrence implies the involvement of genetic, hereditary, and unconventional risk factors. However, there is a lack of updated literature on recent advances in genetic polymorphisms of chronic pancreatitis. Therefore, this review aims to present recent findings on the genetic implications of chronic pancreatitis based on individual gene mechanisms and to discuss epigenetics and epistasis involved in the disease. Four mechanisms have been implicated in the pathogenesis of chronic pancreatitis, including premature activation of proteases, endoplasmic reticulum stress, ductal pathway dysfunction, and inflammatory pathway dysfunction. These mechanisms involve genes such as PRSS1, PRSS2, SPINK, CEL, PNLIP, PNLIPRP2, CFTR, CaSR, CLDN2, Alpha 1 antitrypsin, and GGT1. Studying genetic polymorphisms on the basis of altered genes and their products may aid clinicians in identifying predispositions in patients with and without common risk factors. Further research may also identify associations between genetic predispositions and disease staging or prognosis, leading to personalized treatment protocols and precision medicine.

Keywords

pancreatitis / chronic pancreatitis / genetics / genomics

References

[1] Gullo L, Migliori M, Oláh A. et al. Acute pancreatitis in five European countries: etiology and mortality. Pancreas 2002; 24(03) 223-227

[2] Kleeff J, Whitcomb DC, Shimosegawa T. et al. Chronic pancreatitis. Nat Rev Dis Primers 2017; 3: 17060

[3] Balazs EA, Davies JV, Phillips GO, Scheufele DS. Ppolyanions and their complexes. 3. Reactions of heparin, hyaluronic acid, sodium poly(ethylenesulphonate), sodium poly(styrenesulphonate), and sodium carboxymethylcellulose with hydroxyl radicals and hydrated electrons. J Chem Soc, Perkin Trans 1 1968; 12: 1420-1423

[4] Yadav D, Timmons L, Benson JT, Dierkhising RA, Chari ST. Incidence, prevalence, and survival of chronic pancreatitis: a population-based study. Am J Gastroenterol 2011; 106(12) 2192-2199

[5] Spanier B, Bruno MJ, Dijkgraaf MG. Incidence and mortality of acute and chronic pancreatitis in the Netherlands: a nationwide record-linked cohort study for the years 1995-2005. World J Gastroenterol 2013; 19(20) 3018-3026

[6] Lowenfels AB, Maisonneuve P, Cavallini G. et al; International Pancreatitis Study Group. Pancreatitis and the risk of pancreatic cancer. N Engl J Med 1993; 328(20) 1433-1437

[7] Etemad B, Whitcomb DC. Chronic pancreatitis: diagnosis, classification, and new genetic developments. Gastroenterology 2001; 120(03) 682-707

[8] Frulloni L, Gabbrielli A, Pezzilli R. et al; PanCroInfAISP Study Group. Chronic pancreatitis: report from a multicenter Italian survey (PanCroInfAISP) on 893 patients. Dig Liver Dis 2009; 41(04) 311-317

[9] Coté GA, Yadav D, Slivka A. et al; North American Pancreatitis Study Group. Alcohol and smoking as risk factors in an epidemiology study of patients with chronic pancreatitis. Clin Gastroenterol Hepatol2011; 9 (03) 266-273 , quiz e27

[10] Whitcomb DC, LaRusch J, Krasinskas AM. et al; Alzheimer's Disease Genetics Consortium. Common genetic variants in the CLDN2 and PRSS1-PRSS2 loci alter risk for alcohol-related and sporadic pancreatitis. Nat Genet 2012; 44(12) 1349-1354

[11] Andriulli A, Botteri E, Almasio PL, Vantini I, Uomo G, Maisonneuve P. ad hoc Committee of the Italian Association for the Study of the Pancreas. Smoking as a cofactor for causation of chronic pancreatitis: a meta-analysis. Pancreas 2010; 39(08) 1205-1210

[12] Yadav D, Hawes RH, Brand RE. et al; North American Pancreatic Study Group. Alcohol consumption, cigarette smoking, and the risk of recurrent acute and chronic pancreatitis. Arch Intern Med 2009; 169(11) 1035-1045

[13] Warshaw AL, Richter JM, Schapiro RH. The cause and treatment of pancreatitis associated with pancreas divisum. Ann Surg 1983; 198(04) 443-452

[14] Bertin C, Pelletier AL, Vullierme MP. et al. Pancreas divisum is not a cause of pancreatitis by itself but acts as a partner of genetic mutations. Am J Gastroenterol 2012; 107(02) 311-317

[15] Whitcomb DC. North American Pancreatitis Study Group. Pancreatitis: TIGAR-O version 2 risk/etiology checklist with topic reviews, updates, and use primers. Clin Transl Gastroenterol 2019; 10(06) e00027

[16] Kimura W, Mössner J. Role of hypertriglyceridemia in the pathogenesis of experimental acute pancreatitis in rats. Int J Pancreatol 1996; 20(03) 177-184

[17] Aseervatham GS, Sivasudha T, Jeyadevi R, Arul Ananth D. Environmental factors and unhealthy lifestyle influence oxidative stress in humans: an overview. Environ Sci Pollut Res Int 2013; 20(07) 4356-4369

[18] Chen QY, DesMarais T, Costa M. Metals and mechanisms of carcinogenesis. Annu Rev Pharmacol Toxicol 2019; 59: 537-554

[19] Weizman Z, Picard E, Barki Y, Moses S. Wilson's disease associated with pancreatitis. J Pediatr Gastroenterol Nutr 1988; 7(06) 931-933

[20] Kikuchi M, Hasegawa K, Handa I, Watabe M, Narisawa K, Tada K. Chronic pancreatitis in a child with glycogen storage disease type 1. Eur J Pediatr 1991; 150(12) 852-853

[21] Witt H, Luck W, Becker M. A signal peptide cleavage site mutation in the cationic trypsinogen gene is strongly associated with chronic pancreatitis. Gastroenterology 1999; 117(01) 7-10

[22] Chen JM, Kukor Z, Le Maréchal C. et al. Evolution of trypsinogen activation peptides. Mol Biol Evol 2003; 20(11) 1767-1777

[23] Geisz A, Hegyi P, Sahin-Tóth M. Robust autoactivation, chymotrypsin C independence and diminished secretion define a subset of hereditary pancreatitis-associated cationic trypsinogen mutants. FEBS J 2013; 280(12) 2888-2899

[24] Joergensen MT, Geisz A, Brusgaard K. et al. Intragenic duplication: a novel mutational mechanism in hereditary pancreatitis. Pancreas 2011; 40(04) 540-546

[25] Kereszturi E, Sahin-Tóth M. Intracellular autoactivation of human cationic trypsinogen mutants causes reduced trypsinogen secretion and acinar cell death. J Biol Chem 2009; 284(48) 33392-33399

[26] Chen JM, Raguenes O, Ferec C, Deprez PH, Verellen-Dumoulin C, Andriulli A. The A16V signal peptide cleavage site mutation in the cationic trypsinogen gene and chronic pancreatitis. Gastroenterology 1999; 117(06) 1508-1509

[27] Shibata T, Ogawa M, Matsuda K, Miyauchi K, Yamamoto T, Mori T. Purification and characterization of pancreatic secretory trypsin inhibitor in human gastric mucosa. Clin Chim Acta 1986; 159(01) 27-36

[28] Barkin JS, Fayne SD. Chronic pancreatitis: update 1986. Mt Sinai J Med 1986; 53(05) 404-408

[29] Durbec JP, Sarles H. Multicenter survey of the etiology of pancreatic diseases. Relationship between the relative risk of developing chronic pancreaitis and alcohol, protein and lipid consumption. Digestion 1978; 18(5-6): 337-350

[30] Cheng SH, Gregory RJ, Marshall J. et al. Defective intracellular transport and processing of CFTR is the molecular basis of most cystic fibrosis. Cell 1990; 63(04) 827-834

[31] Primhak RA, Tanner MS. Alpha-1 antitrypsin deficiency. Arch Dis Child 2001; 85(01) 2-5

[32] Witt H, Luck W, Hennies HC. et al. Mutations in the gene encoding the serine protease inhibitor, Kazal type 1 are associated with chronic pancreatitis. Nat Genet 2000; 25(02) 213-216

[33] Witt H, Becker M. Genetics of chronic pancreatitis. J Pediatr Gastroenterol Nutr 2002; 34(02) 125-136

[34] Zhou J, Sahin-Tóth M. Chymotrypsin C mutations in chronic pancreatitis. J Gastroenterol Hepatol 2011; 26(08) 1238-1246

[35] Mayerle J, Sendler M, Hegyi E, Beyer G, Lerch MM, Sahin-Tóth M. Genetics, cell biology,pathophysiology of pancreatitis. Gastroenterology2019; 156 (07) 1951-1968.e1

[36] Rosendahl J, Witt H, Szmola R. et al. Chymotrypsin C (CTRC) variants that diminish activity or secretion are associated with chronic pancreatitis. Nat Genet 2008; 40(01) 78-82

[37] Felderbauer P, Karakas E, Fendrich V, Lebert R, Bartsch DK, Bulut K. Multifactorial genesis of pancreatitis in primary hyperparathyroidism: evidence for “protective” (PRSS2) and “destructive” (CTRC) genetic factors. Exp Clin Endocrinol Diabetes 2011; 119(01) 26-29

[38] Derikx MH, Szmola R, te Morsche RH, Sunderasan S, Chacko A, Drenth JP. Tropical calcific pancreatitis and its association with CTRC and SPINK1 (p.N34S) variants. Eur J Gastroenterol Hepatol 2009; 21(08) 889-894

[39] Sahin-Tóth M. Genetic risk in chronic pancreatitis: the misfolding-dependent pathway. Curr Opin Gastroenterol 2017; 33(05) 390-395

[40] Witt H, Beer S, Rosendahl J. et al. Variants in CPA1 are strongly associated with early onset chronic pancreatitis. Nat Genet 2013; 45(10) 1216-1220

[41] Nilsson J, Bläckberg L, Carlsson P, Enerbäck S, Hernell O, Bjursell G. cDNA cloning of human-milk bile-salt-stimulated lipase and evidence for its identity to pancreatic carboxylic ester hydrolase. Eur J Biochem 1990; 192(02) 543-550

[42] Lombardo D. Bile salt-dependent lipase: its pathophysiological implications. Biochim Biophys Acta 2001; 1533(01) 1-28

[43] Dalva M, El Jellas K, Steine SJ. et al. Copy number variants and VNTR length polymorphisms of the carboxyl-ester lipase (CEL) gene as risk factors in pancreatic cancer. Pancreatology 2017; 17(01) 83-88

[44] Fjeld K, Weiss FU, Lasher D. et al. A recombined allele of the lipase gene CEL and its pseudogene CELP confers susceptibility to chronic pancreatitis. Nat Genet 2015; 47(05) 518-522

[45] Van Itallie CM, Holmes J, Bridges A. et al. The density of small tight junction pores varies among cell types and is increased by expression of claudin-2. J Cell Sci 2008; 121(Pt 3): 298-305

[46] Meriläinen S, Mäkelä J, Anttila V. et al. Acute edematous and necrotic pancreatitis in a porcine model. Scand J Gastroenterol 2008; 43(10) 1259-1268

[47] Vezzoli G, Terranegra A, Arcidiacono T. et al. R990G polymorphism of calcium-sensing receptor does produce a gain-of-function and predispose to primary hypercalciuria. Kidney Int 2007; 71(11) 1155-1162

[48] Novis BH, Young GO, Bank S, Marks IN. Chronic pancreatitis and alpha-1-antitrypsin. Lancet 1975; 2(7938): 748-749

[49] Mihas AA, Hirschowitz BI. Alpha-antitrypsin and chronic pancreatitis. Lancet 1976; 2(7993): 1032-1033

[50] Haber PS, Wilson JS, McGarity BH, Hall W, Thomas MC, Pirola RC. Alpha 1 antitrypsin phenotypes and alcoholic pancreatitis. Gut 1991; 32(08) 945-948

[51] Busslinger M, Moschonas N, Flavell RA. Beta + thalassemia: aberrant splicing results from a single point mutation in an intron. Cell 1981; 27(2, Pt 1): 289-298

[52] Piperno A, Sampietro M, Pietrangelo A. et al. Heterogeneity of hemochromatosis in Italy. Gastroenterology 1998; 114(05) 996-1002

[53] Camaschella C, Roetto A, Calì A. et al. The gene TFR2 is mutated in a new type of haemochromatosis mapping to 7q22. Nat Genet 2000; 25(01) 14-15

[54] del Rosario JF, Putnam PE, Orenstein DM. Chronic pancreatitis in a patient with cystic fibrosis and clinical pancreatic insufficiency. J Pediatr 1995; 126(06) 951-952

[55] Vassalli P. The pathophysiology of tumor necrosis factors. Annu Rev Immunol 1992; 10: 411-452

[56] Yang Y, Wang X, Moore DR, Lightfoot SA, Huycke MM. TNF-α mediates macrophage-induced bystander effects through Netrin-1. Cancer Res 2012; 72(20) 5219-5229

[57] Liu Y, Ho RC, Mak A. Interleukin (IL)-6, tumour necrosis factor alpha (TNF-α) and soluble interleukin-2 receptors (sIL-2R) are elevated in patients with major depressive disorder: a meta-analysis and meta-regression. J Affect Disord 2012; 139(03) 230-239

[58] Iwamoto S, Iwai S, Tsujiyama K. et al. TNF-alpha drives human CD14+ monocytes to differentiate into CD70+ dendritic cells evoking Th1 and Th17 responses. J Immunol 2007; 179(03) 1449-1457

[59] Talar-Wojnarowska R, Gasiorowska A, Smolarz B, Romanowicz-Makowska H, Kulig A, Malecka-Panas E. Tumor necrosis factor alpha and interferon gamma genes polymorphisms and serum levels in pancreatic adenocarcinoma. Neoplasma 2009; 56(01) 56-62

[60] Zhong Y, Zou R, Cao J, Peng M. Glutathione S-transferase M1 and glutathione S-transferase T1 genotype in chronic pancreatitis: a meta-analysis. J Int Med Res 2015; 43(01) 9-16

[61] Manjari KS, Jyothy A, Kumar PS, Prabhakar B, Nallari P, Venkateshwari A. Association of matrix metalloproteinase-7 (-181A/G) promoter polymorphism in chronic pancreatitis. Indian J Med Res 2014; 140(05) 609-615

[62] Shrikhande SV, Martignoni ME, Shrikhande M. et al. Comparison of histological features and inflammatory cell reaction in alcoholic, idiopathic and tropical chronic pancreatitis. Br J Surg 2003; 90(12) 1565-1572

[63] Noone PG, Zhou Z, Silverman LM, Jowell PS, Knowles MR, Cohn JA. Cystic fibrosis gene mutations and pancreatitis risk: relation to epithelial ion transport and trypsin inhibitor gene mutations. Gastroenterology 2001; 121(06) 1310-1319

[64] Schneider A, Larusch J, Sun X. et al. Combined bicarbonate conductance-impairing variants in CFTR and SPINK1 variants are associated with chronic pancreatitis in patients without cystic fibrosis. Gastroenterology 2011; 140(01) 162-171

[65] Maruyama K, Harada S, Yokoyama A. et al. Association analyses of genetic polymorphisms of GSTM1, GSTT1, NQO1, NAT2, LPL, PRSS1, PSTI, and CFTR with chronic alcoholic pancreatitis in Japan. Alcohol Clin Exp Res 2010; 34(Suppl. 01) S34-S38

[66] Nencioni L, Pizza M, Bugnoli M. et al. Characterization of genetically inactivated pertussis toxin mutants: candidates for a new vaccine against whooping cough. Infect Immun 1990; 58(05) 1308-1315

[67] Zhong Y, Dong G, Luo H. et al. Induction of brain CYP2E1 by chronic ethanol treatment and related oxidative stress in hippocampus, cerebellum, and brainstem. Toxicology 2012; 302(2-3): 275-284

[68] Zhong Y, Cao J, Zou R, Peng M. Genetic polymorphisms in alcohol dehydrogenase, aldehyde dehydrogenase and alcoholic chronic pancreatitis susceptibility: a meta-analysis. Gastroenterol Hepatol 2015; 38(07) 417-425

[69] Foster JR, Idle JR, Hardwick JP, Bars R, Scott P, Braganza JM. Induction of drug-metabolizing enzymes in human pancreatic cancer and chronic pancreatitis. J Pathol 1993; 169(04) 457-463

[70] Stamatoyannopoulos G, Chen SH, Fukui M. Liver alcohol dehydrogenase in Japanese: high population frequency of atypical form and its possible role in alcohol sensitivity. Am J Hum Genet 1975; 27(06) 789-796

[71] Aguilar JS, Ochoa EL, De Robertis E. Reconstitution of solubilized atrial cholinergic muscarinic receptors in liposomes. Neurochem Res 1987; 12(01) 83-91

RIGHTS & PERMISSIONS

2023 Global Medical Genetics